Win et al. estimated the risks of subsequent cancers following an initial EC for women carrying MMR gene mutations, and they observed an increased risk for a wide range of cancers, including colorectal cancer, kidney cancer, renal pelvis cancer, ureter cancer, urinary bladder cancer, and breast cancer compared with the general population.9 This evidence concerns the gene MRC1 and colorectal cancer.